Immunoengineering morning program

September 17, 2021


All events are located at David Rubenstein Forum, Room 701
All events listed in CDT

9 A.M.

Opening statements

9:15 A.M.

Faculty TED talks

  • Developing microbiome modulating therapeutics
    • Talk presented by Cathryn Nagler, Bunning Family Professor in the Department of Pathology, Pritzker School of Molecular Engineering, and the College
  • Machine learning from genomic data to predict cellular transformations
    • Talk presented by Samantha Riesenfeld, assistant professor of molecular engineering and genetic medicine
  • Getting to know your cells deeper: Empowering and enriching the information and data content gleaned from single cells in real-time
    • Talk presented by Savas Tay, professor of molecular engineering
10 A.M.


10:15 A.M.

Panel discussion: Industry-academic synergies

A panel discussion moderated by Shann Yu, scientific director of the Chicago Immunoengineering Innovation Center, featuring:

  • Jay Cui, PhD’09, MBA’15, principal at Abingworth Management
  • Jeffrey HubbellEugene Bell Professor in Tissue Engineering and vice dean and executive officer
  • Jasmina Marjanovic, PhD’10, director at Abbvie Ventures
  • Paul Song, co-founder and CEO of Fuse Therapeutics & Virafuse Biotherapeutics.
11:15 A.M.

Grand challenges keynote: Manipulating tolerance in autoimmunity and organ transplantation

Keynote address by Jeffrey Bluestone, president and chief executive officer of Sonoma Biotherapeutics and the A.W. and Mary Margaret Clausen Distinguished Professor at the Diabetes Center of The University of California, San Francisco.

Scroll to Top